New Heart-Zapping device aims to control dangerous irregular heartbeat
NCT ID NCT06696170
Summary
This study is testing a new medical device called the CellFX Nano-PFA 360 Catheter for treating atrial fibrillation (AFib), a common irregular heartbeat. The device uses brief electrical pulses to create scar tissue in the heart to block the faulty electrical signals causing AFib. The main goals are to see if the procedure is safe and if it can successfully isolate the problem areas in the heart to control the arrhythmia. Researchers will follow 60 participants for up to a year after their procedure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (PAROXYSMAL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hartcentrum Hasselt Research Center /Jessa Hospital
ACTIVE_NOT_RECRUITINGHasselt, Belgium
-
Na Homolce Hospital
RECRUITINGPrague, Czechia
Contact
Contact
-
Policlinico Tor Vergata Hospital
RECRUITINGRoma, Italy
Contact
Contact
Conditions
Explore the condition pages connected to this study.